Dr. Hensley's research interests are broadly focused on trying to understand the mechanisms of pulmonary complications post-HCT through microbial sequencing techniques and host response phenotyping. He has additional interest in outcomes of CAR-T and immunotherapy-related critical illness. He also has interests in both acute and late complications of HCT including infectious and non-infectious complications such as pulmonary graft-versus-host disease.
Dr. Hensley's clinical interest is in the care of patients with complications of cancer treatment. Specifically, he focuses on the care of patients undergoing hematopoietic cell transplant, cellular therapies, and immunotherapy.
Dr. Hensley educates and trains providers on the management of pulmonary and critical illness complications post hematopoietic cell tranplant, CAR-T, and immunotherapy.
- BS, University of Kentucky, 2007
- MPH, University of Kentucky, 2009
- MD, University of Kentucky, 2013
- Residency, Internal Medicine & Pediatrics, University of Pittsburgh Medical Center, 2017
- Fellowship, Pulmonary and Critical Care, University of Michigan, 2020
Education & Training
Haidar G, Jacobs JL, Kramer KH, Naqvi A, Heaps A, McCormick KD, Sobolewski MD, Bushunow V, Farah R, Hensley M, Hsu YS, Johnson B, Klamar-Blain C, Leen AM, Marshall WL, Miller M, Patel B, Atillasoy E, Mellors JW, et all. Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients. Clin Infect Dis. 2023; Sep 11;77(5): 696-702.
Gutierrez C, Brown ART, May HP, Beitinjaneh A, Stephens RS, Rajendram P, Nates JL, Pastores SM, Dharshan A, de Moraes AG, Hensley MK, Feng L, Brudno JN, Athale J, Ghosh M, Westin J, Kostelecky N, Mian A, Herr MM, et all. Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study. Crit Care Med. 2022; Jan 1;50(1): 81-92.
Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Staines B, Heaps A, Sobolewski MD, Rennick LJ, Macatangay BJC, Klamar-Blain C, Kitsios GD, Methé B, Mellors JW, McCormick KD, Mellors JW, Morris A, Haidar G, et all. Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study. Clin Infect Dis. 2021; Aug 2;73(3): e815-e821.
Hensley MK, Donnelly JP, Carlton EF, Prescott HC. Epidemiology and Outcomes of Cancer-Related Versus Non-Cancer-Related Sepsis Hospitalizations. Crit Care Med. 2019; Oct;47(10): 1310-1316.
- ATS Abstract Award, 2019
- Outstanding Subspecialty Teaching Award, 2021
- Medicine-Pediatrics Champion Award, 2022
- Excellence in Patient Experience Award, 2023
